BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26485239)

  • 1. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
    Martires KJ; Ra S; Abdulla F; Cassarino DS
    Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
    Plaza JA; Feldman AL; Magro C
    J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages.
    De Souza A; Tinguely M; Burghart DR; Berisha A; Mertz KD; Kempf W
    J Cutan Pathol; 2016 Jul; 43(7):579-88. PubMed ID: 27080437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
    Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
    Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
    Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Kempf W
    Surg Pathol Clin; 2014 Jun; 7(2):203-28. PubMed ID: 26837199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
    Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
    Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
    Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
    J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
    McQuitty E; Curry JL; Tetzlaff MT; Prieto VG; Duvic M; Torres-Cabala C
    J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Cutaneous CD8(+) CD30(+) Anaplastic Large Cell Lymphoma: An Unusual Case with a High Ki-67 index-A Short Review.
    Nasit JG; Patel SC
    Indian J Dermatol; 2015; 60(4):373-7. PubMed ID: 26288406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.
    Plaza JA; Ortega P; Lynott J; Mullane M; Kroft S; Olteanu H
    Am J Dermatopathol; 2010 Jul; 32(5):489-91. PubMed ID: 20442639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ lymphomatoid papulosis and its differential diagnosis.
    Magro CM; Crowson AN; Morrison C; Merati K; Porcu P; Wright ED
    Am J Clin Pathol; 2006 Apr; 125(4):490-501. PubMed ID: 16627259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Kempf W
    Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck.
    Wang W; Cai Y; Sheng W; Lu H; Li X
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jan; 117(1):96-104. PubMed ID: 24332333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas.
    Kempf W; Kazakov DV; Schärer L; Rütten A; Mentzel T; Paredes BE; Palmedo G; Panizzon RG; Kutzner H
    Am J Surg Pathol; 2013 Jan; 37(1):1-13. PubMed ID: 23026936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.